Work

Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma: A Swedish retrospective real-world study (NEO-MEL).

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e21563

Authors: Axel Nelson, Ellen Krabbe, Karl Björksrtöm, Braslav Jovanovic, Christian U. Blank, Gustav J. Ullenhag, Hildur Helgadottir, Lars Ny, Roger Olofsson Bagge

Institutions: Sahlgrenska University Hospital, University of Gothenburg, Karolinska University Hospital, Karolinska Institutet, The Netherlands Cancer Institute, Uppsala University, Uppsala University Hospital

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Svenska Sällskapet för Medicinsk Forskning, Vetenskapsrådet

Awards: Modern immunterapi i kombination med regional cancer behandling för patienter med malignt melanom - ett translationellt forskningsprojekt inkluderandes två kliniska studier, G3579604610

OpenAlex ID: W4410804777

FWCI:

Cites:

Cited by:

Related to: 10